BOUNDLESS BIO, INC. Increase (Decrease) in Prepaid Expense and Other Assets
BOUNDLESS BIO, INC. (BOLD) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-07
- BOUNDLESS BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$772.00K, a 282.08% decline year-over-year.
- BOUNDLESS BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$250.00K.
- BOUNDLESS BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$569.00K.
- BOUNDLESS BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $27.00K.
- BOUNDLESS BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$332.00K, a 209.93% decline from fiscal 2024.
- BOUNDLESS BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $302.00K.
- BOUNDLESS BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$85.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$772.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$1.02M 10-Q · filed 2026-08-07 | -$1.59M derived: sum of 3 quarters · filed 2026-08-07 | -$1.56M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$250.00K 10-Q · filed 2026-05-08 | -$819.00K derived: sum of 2 quarters · filed 2026-05-08 | -$792.00K derived: sum of 3 quarters · filed 2026-05-08 | -$368.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$569.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$542.00K derived: sum of 2 quarters · filed 2026-03-09 | -$118.00K derived: sum of 3 quarters · filed 2026-08-07 | -$332.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $451.00K derived: sum of 2 quarters · filed 2026-08-07 | $237.00K 10-Q · filed 2025-11-05 | -$760.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $210.00K 10-Q · filed 2026-08-07 | -$787.00K derived: sum of 3 quarters · filed 2026-08-07 | -$1.34M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$214.00K 10-Q · filed 2026-05-08 | -$1.21M derived: sum of 2 quarters · filed 2026-05-08 | -$1.76M derived: sum of 3 quarters · filed 2026-05-08 | -$613.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$997.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$1.55M derived: sum of 2 quarters · filed 2026-03-09 | -$399.00K derived: sum of 3 quarters · filed 2026-03-09 | $302.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | -$550.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $598.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.30M 10-Q · filed 2025-11-05 | $1.21M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.85M 10-Q · filed 2025-08-05 | $1.76M derived: sum of 3 quarters · filed 2025-08-05 | $1.42M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $701.00K 10-Q · filed 2025-05-09 | $614.00K derived: sum of 2 quarters · filed 2025-05-09 | $268.00K derived: sum of 3 quarters · filed 2025-05-09 | $391.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$433.00K derived: sum of 2 quarters · filed 2025-03-27 | -$310.00K derived: sum of 3 quarters · filed 2025-03-27 | -$85.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$223.00K derived: sum of 2 quarters · filed 2024-11-07 | $2.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $348.00K 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $225.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |